Pharmaceutical Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), Application (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat), Function (Stabilizing, Thickening, Gelling), Region - Global Forecasts to 2027

The global Pharmaceutical Gelatin Market in terms of revenue was estimated to be worth $1.1 billion in 2022 and is poised to reach $1.5 billion by 2027, growing at a CAGR of 5.5% from 2022 to 2027.

Growth of this market is attributable to various factors such as rising demand for pharma gelatin in vaccines, tablets, and other applications. Furthermore, the launch of the novel, technologically advanced, and user-friendly pharma gelatin is likely to increase global demand.

Emerging economies such as the Asia Pacific, the Middle East, Latin America, and Africa provide significant opportunities for the growth of the market. Global raw gelatin and gelatin capsule manufacturers have been capitalizing on this demand by expanding their business presence and production capacities in these regions. The increasing demand in emerging economies, coupled with lower raw material and labor costs, offer lucrative growth opportunities for the growth of the market during the forecast period.

Get PDF Sample Report + All Related Table and Graphs @: https://www.reportspublisher.com/report/Pharmaceutical-Gelatin-Market/request-sample

Key players in the pharmaceutical gelatin market includes Darling Ingredients Inc. (US), Nitta Gelatin Inc (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt (France), among others.

The global pharmaceutical gelatin market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America reported for the largest share of the pharmaceutical gelatin market followed by Europe and Asia Pacific respectively. Asia Pacific is anticipated to grow at faster pace owing to various factors such as availability of raw materials and the presence of capsule manufactures in the region. Furthermore, geographical expansion by key market players in the Asia Pacific region is likely to increase the demand subsequently projecting the market growth during the forecast period.

Based on application, the pharmaceutical gelatin market is segmented into hard capsules, softgel capsules, tablets, absorbable hemostats & other applications. The softgel capsules segment is expected to witness the highest growth in the pharmaceutical gelatin market during the forecast period. The softgel capsules are beneficial for low-dose lipid-soluble drugs as they permit more content uniformity between dosage units are likely to increase the demand, subsequently impacting the growth of the segment.

Based on function, the market is segmented into stabilizing agents, thickening agents and gelling agents & other functions. Stabilizing agents held a dominant share in the function segment. Stabilizing agent held dominant share in pharmaceutical gelatin market. Increasing use of gelatin as stabilizer in vaccines is likely to upsurge the segmental growth. Furthermore, gelatin also protects vaccine viruses from freeze-drying or heat, during delivery and transport.

Interested in Purchasing this Report? Click here @ https://www.reportspublisher.com/checkout?report=RP-205854&type=single

Based on type, the market is segmented into type A and type B gelatin. Type B segment held largest share in pharmaceutical gelatin market. The dominance is attributable to various factors such as low production cost owing to easy availability of raw material and its use in various applications across pharmaceutical industry.

This report categorizes the pharmaceutical gelatin market into the following segments

By Application
• Hard capsules
• Softgel capsules
• Tablets
• Absorbable Hemostats
• Other applications

By Source
• Porcine
• Bovine skin
• Bovine bone
• Marine
• Poultry

By Function
• Stabilizing agent
• Thickening agent
• Gelling agent & other function

Get Customized report at https://www.reportspublisher.com/report/Pharmaceutical-Gelatin-Market/request-customization

Recent Developments

• In May 2021, Darling Ingredients Inc. announced that its Rousselot brand expanded its range of purified pharmaceutical-grade modified gelatin with the launch of X-Pure GelDAT - Gelatin Desaminotyrosine for biomedical applications.
• In July 2022, Gelita opened a biotech hub for developing proteins from biotechnological processes for applications in nutrition, cosmetics, and pharmaceutical and medical products.

Frequently Asked Questions (FAQs):
What is the size of Pharmaceutical Gelatin Market?
Why is Pharmaceutical Gelatin Market Growing?
Who all are the prominent players of Pharmaceutical Gelatin Market?

Alex
USA Office
1050 West Lakes Drive, West Covina,
California 91790, Los Angeles, United States
E-mail: help@reportspublisher.com
Phone: +1-323-982-8916

REPORTS PUBLISHER is a market research and consultative company that provides market research reports and business insights to large and small & medium enterprises. The company supports its clients to conceive business policies and accomplish sustainable growth in their particular market domain.

This release was published on openPR.